Increased serum endotoxin levels as biomarker in acute exacerbations of COPD.

E. Papatsanis (Homburg, Germany), J. Classen (Homburg, Germany), J. Demandt (Homburg, Germany), M. Patalong-Dahm (Homburg, Germany), T. Stegmaier (Homburg, Germany), C. Herr (Homburg, Germany), C. Beißwenger (Homburg, Germany), G. Vella (Homburg, Germany), F. Ritzmann (Homburg, Germany), F. Trudzinski (Homburg, Germany), T. Dinh (Homburg, Germany), P. Lepper (Homburg, Germany), S. Fähndrich (Homburg, Germany), R. Bals (Homburg, Germany)

Source: International Congress 2018 – Biomarkers of COPD
Session: Biomarkers of COPD
Session type: Thematic Poster
Number: 4073
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Papatsanis (Homburg, Germany), J. Classen (Homburg, Germany), J. Demandt (Homburg, Germany), M. Patalong-Dahm (Homburg, Germany), T. Stegmaier (Homburg, Germany), C. Herr (Homburg, Germany), C. Beißwenger (Homburg, Germany), G. Vella (Homburg, Germany), F. Ritzmann (Homburg, Germany), F. Trudzinski (Homburg, Germany), T. Dinh (Homburg, Germany), P. Lepper (Homburg, Germany), S. Fähndrich (Homburg, Germany), R. Bals (Homburg, Germany). Increased serum endotoxin levels as biomarker in acute exacerbations of COPD.. 4073

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD
Source: International Congress 2017 – COPD biomarkers
Year: 2017

Serum magnesium levels in acute exacerbation of COPD
Source: Annual Congress 2007 - Exacerbations of COPD
Year: 2007


Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009


Plasma biomarkers and response to therapy at exacerbation of COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 39s
Year: 2007

Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016

Activin-A levels in sputum and serum of COPD, asthma and ACOS patients during acute exacerbation and at baseline
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017

Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients.
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020


Change of induced sputum TNF-a and sTNF-R55,75 levels in patients with acute exacerbations of COPD
Source: Annual Congress 2007 - Respiratory pathophysiology
Year: 2007


Sputum VEGF level increases with treatment of COPD acute exacerbation
Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Year: 2012


Evaluation of procalcitonin (PCT) and neopterin levels in acute exacerbations of COPD
Source: Annual Congress 2005 - Acute and chronic infections in COPD
Year: 2005


Elevated serum inflammatory markers in patients with stable COPD
Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Year: 2009


Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018



Serum SP-A and SP-D levels in patients admitted to the hospital with acute COPD exacerbation
Source: International Congress 2016 – Inflammatory biomarkers in airway diseases
Year: 2016


The assesment of serum TNFα levels in COPD acute exacerbation and the effects of inhaler steroids on clinical and inflammatory determinants
Source: Eur Respir J 2002; 20: Suppl. 38, 312s
Year: 2002

Serum angiopoietin-2 levels in stable and exacerbated chronic obstructive pulmonary disease
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015


Are C-reactive protein levels associated with bacteria in COPD exacerbations?
Source: Eur Respir J 2015; 45: 1515-1516
Year: 2015


Are C-reactive protein levels associated with bacteria in COPD exacerbations?
Source: Eur Respir J 2015; 45: 1514-1515
Year: 2015


Effect of systemic steroid treatment on serum leptin levels in patients with COPD exacerbation
Source: Eur Respir J 2005; 26: Suppl. 49, 284s
Year: 2005

Serum G-CSF is a non-invasive biomarker classifying bacterial/neutrophilic COPD exacerbations
Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Year: 2020


The relationhip between serum levels of Surfactant protein D in COPD exacerbation severity and mortality
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018